J. Permert et al., IMPROVED GLUCOSE-METABOLISM AFTER SUBTOTAL PANCREATECTOMY FOR PANCREATIC-CANCER, British Journal of Surgery, 80(8), 1993, pp. 1047-1050
Diabetes occurs frequently in patients with pancreatic cancer. To inve
stigate the impact of tumour removal, seven patients were studied befo
re and after 85 per cent subtotal pancreatectomy for adenocarcinoma of
the pancreas. The frequency of diabetes was determined by the oral gl
ucose tolerance test. Fasting levels of C peptide and insulin were mea
sured in plasma, and insulin secretion was investigated by hyperglycae
mic glucose clamp and glucagon stimulation. Six of the seven patients
were diabetic before surgery and four required insulin treatment. Impr
ovements in diabetic status and glucose metabolism were found in all s
even patients after operation, as demonstrated by increased glucose me
tabolic capacity during hyperglycaemia. This occurred despite a postop
erative reduction in insulin secretion and is explained by the observe
d augmentation of whole-body insulin sensitivity after surgery. A diab
etogenic factor may be produced by pancreatic adenocarcinoma that may
be responsible, directly or indirectly, for the high frequency of diab
etes in patients with pancreatic cancer.